136 related articles for article (PubMed ID: 16483834)
41. Cytotoxicity and type of cell death induced by local anesthetics in human oral normal and tumor cells.
Kobayashi K; Ohno S; Uchida S; Amano O; Sakagami H; Nagasaka H
Anticancer Res; 2012 Jul; 32(7):2925-33. PubMed ID: 22753757
[TBL] [Abstract][Full Text] [Related]
42. [An experimental study of human tracheal epithelial transfer of human neutrophil defensin gene].
Huang N; Tang B; Wu Q; Wang B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):295-7. PubMed ID: 11285840
[TBL] [Abstract][Full Text] [Related]
43. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
[TBL] [Abstract][Full Text] [Related]
44. Decreased expression of Annexin A1 correlates with pathologic differentiation grade in oral squamous cell carcinoma.
Zhang L; Yang X; Zhong LP; Zhou XJ; Pan HY; Wei KJ; Li J; Chen WT; Zhang ZY
J Oral Pathol Med; 2009 Apr; 38(4):362-70. PubMed ID: 18673418
[TBL] [Abstract][Full Text] [Related]
45. MICA and MICB overexpression in oral squamous cell carcinoma.
Liu CJ; Lui MT; Chen HL; Lin SC; Chang KW
J Oral Pathol Med; 2007 Jan; 36(1):43-7. PubMed ID: 17181741
[TBL] [Abstract][Full Text] [Related]
46. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships of alpha, beta-unsaturated ketones as assessed by their cytotoxicity against oral tumor cells.
Nakayachi T; Yasumoto E; Nakano K; Morshed SR; Hashimoto K; Kikuchi H; Nishikawa H; Kawase M; Sakagami H
Anticancer Res; 2004; 24(2B):737-42. PubMed ID: 15161020
[TBL] [Abstract][Full Text] [Related]
48. Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Febriyanti Ayuningtyas N; Subarnbhesaj A; Nguyen PT; Shrestha M; Haing S; Ohta K; Takata T
PLoS One; 2018; 13(1):e0191683. PubMed ID: 29381751
[TBL] [Abstract][Full Text] [Related]
49. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
Diamond ME; Sun L; Ottaviano AJ; Joseph MJ; Munshi HG
J Cell Sci; 2008 Jul; 121(Pt 13):2197-207. PubMed ID: 18544635
[TBL] [Abstract][Full Text] [Related]
50. Induction of non-apoptotic cell death by morphinone in human promyelocytic leukemia HL-60 cells.
Takeuchi R; Hoshijima H; Nagasaka H; Chowdhury SA; Kikuchi H; Kanda Y; Kunii S; Kawase M; Sakagami H
Anticancer Res; 2006; 26(5A):3343-8. PubMed ID: 17094451
[TBL] [Abstract][Full Text] [Related]
51. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
52. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
[TBL] [Abstract][Full Text] [Related]
53. Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer.
Hamakawa H; Nakashiro K; Sumida T; Shintani S; Myers JN; Takes RP; Rinaldo A; Ferlito A
Head Neck; 2008 Jun; 30(6):800-9. PubMed ID: 18429007
[TBL] [Abstract][Full Text] [Related]
54. Functional role of matrix metalloproteinase-28 in the oral squamous cell carcinoma.
Lin MH; Liu SY; Su HJ; Liu YC
Oral Oncol; 2006 Oct; 42(9):907-13. PubMed ID: 16730219
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
Ding X; Sun J; Wang L; Li G; Shen Y; Zhou X; Chen W
Oncol Rep; 2008 Nov; 20(5):1041-5. PubMed ID: 18949399
[TBL] [Abstract][Full Text] [Related]
56. [Experimental study on antitumor effect in vitro of modified DNL of oral squamous cell carcinoma with TNF-alpha gene].
Li T; Qiu W; He R
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Sep; 32(5):262-4. PubMed ID: 11189281
[TBL] [Abstract][Full Text] [Related]
57. Effects of defensin and lactoferrin on functional activity of endothelial cells in vitro.
Krylov AV; Kisseleva EP; Aleshina GM; Shamova OV; Kokryakov VN
Bull Exp Biol Med; 2007 Sep; 144(3):331-4. PubMed ID: 18457029
[TBL] [Abstract][Full Text] [Related]
58. A Tetrameric Peptide Derived from Bovine Lactoferricin Exhibits Specific Cytotoxic Effects against Oral Squamous-Cell Carcinoma Cell Lines.
Solarte VA; Rosas JE; Rivera ZJ; Arango-Rodríguez ML; García JE; Vernot JP
Biomed Res Int; 2015; 2015():630179. PubMed ID: 26609531
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium.
Petro BJ; Tan RC; Tyner AL; Lingen MW; Watanabe K
Oral Oncol; 2004 Nov; 40(10):1040-7. PubMed ID: 15509496
[TBL] [Abstract][Full Text] [Related]
60. Growth of normal oral keratinocytes and squamous cell carcinoma cells in a novel protein-free defined medium.
Kamata N; Yokoyama K; Fujimoto R; Ueda N; Hayashi E; Nakanishi H; Nagayama M
In Vitro Cell Dev Biol Anim; 1999; 35(10):635-41. PubMed ID: 10614874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
